Outlook Therapeutics Inc (OTLK) is lower by -19.05% in a Week, Should You Accumulate?

Outlook Therapeutics Inc (OTLK) is around the top of the Biotechnology industry according to InvestorsObserver. OTLK received an overall rating of 60, which means that it scores higher than 60 percent of all stocks. Outlook Therapeutics Inc also achieved a score of 77 in the Biotechnology industry, putting it above 77 percent of Biotechnology stocks. Biotechnology is ranked 47 out of the 148 industries.

OTLK has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on OTLK!

See Full OTLK Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Outlook Therapeutics Inc Stock Today?

Outlook Therapeutics Inc (OTLK) stock is unmoved -0.39% while the S&P 500 is higher by 0.19% as of 9:30 AM on Wednesday, Nov 8. OTLK is unchanged $0.00 from the previous closing price of $0.51 on volume of 219,200 shares. Over the past year the S&P 500 has risen 14.59% while OTLK is lower by -52.78%. OTLK lost -$0.25 per share the over the last 12 months. Click Here to get the full Stock Report for Outlook Therapeutics Inc stock.